Global Analgesics Market Outlook to 2024 – Projected to Grow at a CAGR of Approx 8% – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Analgesics
Market: Global Industry Trends, Share, Size, Growth, Opportunity and
Forecast 2019-2024”
report has been added to ResearchAndMarkets.com’s
offering.

The global analgesics market was worth US$ 44.3 Billion in 2018. Looking
forward, the global analgesics market is expected to reach a revenue of
US$ 56.8 Billion by 2024, exhibiting a CAGR of around 4% during
2019-2024.

The global analgesics market is expected to exhibit moderate growth over
the next five years. A major factor catalyzing this demand is the strong
growth in the geriatric population. In 2017, between 950 Million-1000
Million people were over the age of 60. We expect these numbers to reach
2100 Million by 2050 accounting for 21% of the total global population.

The rising older population is expected to increase the incidence of
pain arising from a number of chronic and lifestyle diseases. The market
for analgesics is also expected to be catalyzed by a strong drug
pipeline and high unmet needs. We expect a number of new drugs to be
launched in the coming years.

Other major factors catalyzing the analgesics market include changing
lifestyles, rising prevalence of obesity and overweight, rising
prevalence of chronic diseases, etc.

Market Summary

Based on the drug type, the market has been segmented into prescription
analgesics and OTC analgesics. Prescription analgesics currently
dominate the market, holding the largest share.

Based on the drug class, the market has been segmented into opioids,
NSAIDs and others. Opioids currently represents the biggest segment.

Based on the route of administration, the market has been segmented into
oral, parenteral, topical, transdermal and rectal. Currently, oral
dominates the market, holding the largest share.

Based on the pain type, the market has been segmented into
musculoskeletal pain, surgical and trauma pain, cancer pain, neuropathic
pain, migraine, obstetrical pain, fibromyalgia, pain due to burns,
dental/facial pain, paediatric pain and others. Musculoskeletal pain
currently represents the biggest segment.

Based on the application, the market has been segmented into internal
analgesics and external analgesics. Internal analgesics currently
represent the biggest segment.

Region-wise, the market has been segmented into North America, Europe,
Asia Pacific, Middle East and Africa, and Latin America. North America
currently represents the biggest market.

The competitive landscape of the market has also been examined with some
of the key players being Bayer AG, Novartis AG, GlaxoSmithKline PLC,
Pfizer Inc., Johnson & Johnson, Reckitt Benckiser (RB), Endo
Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, Sanofi,
etc.

Key Questions Answered

  • How has the global analgesics market performed so far and how will it
    perform in the coming years?
  • What are the key regional markets in the global analgesics industry?
  • What is the breakup of the global analgesics market on the basis of
    drug type?
  • What is the breakup of the global analgesics market on the basis of
    drug class?
  • What is the breakup of the global analgesics market on the basis of
    route of administration?
  • What is the breakup of the global analgesics market on the basis of
    pain type?
  • What is the breakup of the global analgesics market on the basis of
    application?
  • What are the various stages in the value chain of the global
    analgesics market?
  • What are the key driving factors and challenges in the global
    analgesics market?
  • What is the structure of the global analgesics market and who are the
    key players?
  • What is the degree of competition in the global analgesics market?

Topics Covered

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2
Stakeholders
2.3 Data Sources
2.4 Market Estimation
2.5
Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Properties
4.3 Key
Industry Trends

5 Global Analgesics Market
5.1 Market Overview
5.2 Market
Performance
5.3 Market Breakup by Type
5.4 Market Breakup by
Drug Class
5.5 Market Breakup by RoA
5.6 Market Breakup by
Pain Type
5.7 Market Breakup by Application
5.8 Market Breakup
by Region
5.9 Market Forecast

6 Market Breakup by Type
6.1 Prescription Analgesics
6.2 OTC
Analgesics

7 Market Breakup by Drug Class
7.1 Opioids
7.2 NSAID
7.3
Others

8 Market Breakup by RoA
8.1 Oral
8.2 Parenteral
8.3
Topical
8.4 Transdermal
8.5 Rectal

9 Market Breakup by Pain Type
9.1 Musculoskeletal Pain
9.2
Surgical and Trauma Pain
9.3 Cancer Pain
9.4 Neuropathic Pain
9.5
Migraine
9.6 Obstetrical Pain
9.7 Fibromyalgia
9.8 Pain
due to Burns
9.9 Dental/Facial Pain
9.10 Pediatric Pain
9.11
Others

10 Market Breakup by Application
10.1 Internal Analgesics
10.2
External Analgesics

11 Market Breakup by Region
11.1 North America
11.2 Europe
11.3
Asia Pacific
11.4 Middle East and Africa
11.5 Latin America

12 Global Analgesics Industry: SWOT Analysis
12.1 Overview
12.2
Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Global Analgesics Industry: Value Chain Analysis
13.1 Overview
13.2
Research and Development
13.3 Raw Material Procurement
13.4
Manufacturing
13.5 Marketing
13.6 Distribution
13.7
End-Use

14 Global Analgesics Industry: Porters Five Forces Analysis
14.1
Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power
of Suppliers
14.4 Degree of Competition
14.5 Threat of New
Entrants
14.6 Threat of Substitutes

15 Global Analgesics Industry: Price Analysis
15.1 Price Indicators
15.2
Price Structure
15.3 Margin Analysis

16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3
Profiles of Key Players
16.3.1 Bayer AG
16.3.2 Novartis AG
16.3.3
GlaxoSmithKline PLC
16.3.4 Pfizer Inc.
16.3.5 Johnson & Johnson
16.3.6
Reckitt Benckiser (RB)
16.3.7 Endo Pharmaceuticals
16.3.8
Bristol-Myers Squibb
16.3.9 Eli Lilly and Company
16.3.10
Sanofi

For more information about this report visit https://www.researchandmarkets.com/research/zxq2bg/global_analgesics?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Over
the Counter (OTC) Drugs
, Analgesics